Pulmonary embolism: What have we learned since virchow? Treatment and prevention

Chest

Volumn 122, Issue 5, 2002, Pages 1801-1817

  Dalen, James E ^a  

^a NONE   (United States)

Author keywords

Acute cor pulmonale; Pulmonary embolism; Pulmonary infarction; Venous thromboembolism; Venous thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; DICOUMAROL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHENINDIONE; PHOSPHATIDYLETHANOLAMINE; RECOMBINANT PLASMINOGEN ACTIVATOR; STREPTOKINASE; UROKINASE; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CLINICAL TRIAL; COMPRESSION THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; ECHOCARDIOGRAPHY; EMBOLECTOMY; FEMORAL VEIN; HUMAN; INCIDENCE; INFERIOR CAVA VEIN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; MORTALITY; NONHUMAN; PHLEBOGRAPHY; PLETHYSMOGRAPHY; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROPHYLAXIS; THROMBOEMBOLISM; TREATMENT OUTCOME; VEIN LIGATION;

EID: 0036433372     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.5.1801     Document Type: Article

References (133)

1. PIOPED Investigators. Value of the ventilation/perfusion scan in acute pulmonary embolism. JAMA 1990; 263:2753-2759
2. Barritt DW, Jordan SC. Anticoagulant drugs in treatment of pulmonary embolism: Controlled trial. Lancet 1960; 1:1309-1312
3. Coon WW, Willis PW, Symous MJ. Assessment of anticoagulant treatment of venous thromboembolism. Am J Surg 1969; 170:559-567
4. Zilliacus H. On specific treatment of thrombosis and pulmonary embolism with anticoagulants, with particular reference to postthrombotic sequelae: Results of 5 years' treatment of thrombosis and pulmonary embolism at series of Swedish hospitals during years 1940-1945. Acta Med Scand 1946; 171(suppl):1-221
5. Hermann RE, Davis JH, Holden WD. Pulmonary embolism: A clinical and pathologic study with emphasis on the effect of prophylactic therapy with anticoagulants. Am J Surg 1961; 102:19-28
6. Morrell MT, Truelove SC, Barr A. Pulmonary embolism. BMJ 1963; 2:830-835
7. Trendelenburg F. Ueber die operative behandlung der embolie der lungenarterie. Arch Klin Chir 1908; 86:686-700
8. Homans J. Thrombosis of the deep veins of the lower leg, causing pulmonary embolism. N Engl J Med 1934; 211: 993-997
9. Murray GDW, Best CH. Heparin and thrombosis: The present situation. JAMA 1938; 110:118-122
10. Butt HR, Allen EV, Bollman JL. A preparation from spoiled sweet clover which prolongs coagulation and prothrombin time in the blood: Preliminary report of experimental and clinical studies. Proc Staff Mtg, Mayo Clinic 1941; 16: 388-395
11. Sevitt S, Gallagher NG. Prevention of venous thrombosis and pulmonary embolism in injured patients. Lancet 1959; 2:981-989
12. Collins CG, Jones JR, Nelson EW. Surgical treatment of pelvic thrombophlebitis: Ligation of inferior vena cava and ovarian veins. New Orleans Med Sci J 1943; 329-334
13. Hansen PF, Jorgensen M, Kjeldgaard NO, et al. Urokinase: An activator of plasminogen from human urine; experiences with intravenous application on twenty-two patients. Angiology 1961; 12:367-371
14. The Urokinase-pulmonary embolism trial: A national cooperative study. Circulation 1973; 47 (2 suppl):II1-II108
15. Browse NL, James DCO. Streptokinase and pulmonary embolism. Lancet 1964; 2:1039-1043
16. Bounameaux H, Vermylen J, Collen D. Thrombolytic treatment with recombinant tissue-type plasminogen activator in a patient with massive pulmonary embolism. Ann Intern Med 1985; 103:64-66
17. Mobin-Uddin K, McLean R, Bolooki H, et al. Caval interruption for prevention of pulmonary embolism. Arch Surg 1969; 99:711-715
18. Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998; 338:409-415
19. Greenfield LJ, Bruce TA, Nichols NB. Transvenous pulmonary embolectomy by catheter device. Ann Surg 1971; 174:881-886
20. Holm HA, Ly B, Handeland GF, et al. Subcutaneous heparin treatment of deep venous thrombosis: A comparison of unfractionated and low molecular weight heparin. Haemostasis 1986; 16(suppl2):30-37
21. Hull RD, Raskob GE, Pineo GF, et al. Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis. N Engl J Med 1992; 326:975-982
22. UPET. Urokinase-streptokinase embolism trial: Phase 2 results. JAMA 1974; 229:1606-1613
23. Levine M, Hirsh J, Weitz J, et al. A randomized trial of single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism. Chest 1990; 98:1473-1479
24. PIOPED Investigators. Tissue plasminogen activator for the treatment of acute pulmonary embolism. Chest 1990; 97: 528-533
25. Thery C, Simonneau G, Meyer G, et al. Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (fraxi-parine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism: A dose-ranging study. Circulation 1992; 85:1380-1389
26. Prandoni P, Lensing AWA, Buller HR, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 1992; 339:441-445
27. Simonneau G, Sors H, Charbonnier B, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997; 337: 663-669
28. Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337:657-662
29. Meyer JA. Friedrich Trendelenburg and the surgical approach to massive pulmonary embolism. Arch Surg 1990; 125:1202-1205
30. Crafoord C. Two cases of obstructive pulmonary embolism successfully operated upon. Acta Chir Scand 1928; 114:172-186
31. Steenburg RW, Warren R, Wilson RE, et al. A new look at pulmonary embolectomy. Surg Gynecol Obstet 1958; 107:214-220
32. Cooley DA, Beall AC, Alexander JK. Acute massive pulmonary embolism. JAMA 1961; 177:283-286
33. Stoney WS, Jacobs JK, Collins HA. Pulmonary embolism and embolectomy. Surg Gynecol Obstet 1963; 116:292-296
34. Sautter RD, Lawton BR, Magin OE, et al. Pulmonary embolectomy: Report of a case with preoperative and post-operative angiograms. N Engl J Med 1963; 269:997-999
35. Del Campo CD. Pulmonary embolectomy: A review. Can J Surg 1985; 28:111-113
36. Meyer G, Tamisier D, Sors H, et al. Pulmonary embolec-tomy: A 20 year experience at one center. Ann Thorac Surg. 1991; 51:232-236
37. Greenfield LJ, Kimmell GO, McCurdy WC. Transvenous removal of pulmonary emboli by vacuum-cup catheter technique. J Surg Res 1969; 9:347-352
38. Greenfield LJ, Bruce TA, Nichols NB. Transvenous pulmonary embolectomy by catheter device. Ann Surg 1971; 174:881-886
39. Greenfield LJ, Proctor MC, Williams DM, et al. Long-term, experience with transvenous catheter pulmonary embolectomy. J Vasc Surg 1993; 18:450-457
40. Alpert JS, Smith R, Carlson J, et al. Mortality in patients treated for pulmonary embolism. JAMA 1976; 236:1477-1480
41. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis 1975; 17:259-270
42. Greenfield LJ, Langham MR. Surgical approaches to thromboembolism. Br J Surg 1984; 71:968-970
43. The UKEP study: Multicentre clinical trial on two local regimens of urokinase in massive pulmonary embolism. Eur Heart J 1987; 8:2-10
44. Diehl JL, Meyer G, Igual J, et al. Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolism. Am J Cardiol 1992; 70:1477-1480
45. Gulba DC, Schmid C, Borst HG, et al. Medical compared with surgical treatment for massive pulmonary embolism. Lancet 1994; 343:576-577
46. Byrne JJ. Phlebitis: A study of 748 cases at the Boston City Hospital. N Engl J Med 1955; 253:579-586
47. Crane C. Deep venous thrombosis and pulmonary embolism: Experience with 391 patients treated with heparin and 126 patients treated by venous division with a review of the literature. N Engl J Med 1957; 257:147-157
48. Homans J. Deep quiet venous thrombosis in the lower limb. Surg Gynecol Obstet 1944; 79:70-82
49. Kempczinski RF. Surgical prophylaxis of pulmonary embolism. Chest 1986; 89:384S-388S
50. Dale WA. Ligation of the inferior vena cava for thromboembolism. Surgery 1958; 43:24-44
51. Crane C. Femoral vs cava interruption for venous thromboembolism. N Engl J Med 1964; 270:819-822
52. Homans J. The management of recovery from venous thrombosis in the lower limbs. Surgery 1949; 26:8-15
53. Greenfield LJ, McCurdy JR, Brown PP, et al. A new intracaval filter permitting continued flow and resolution of emboli. Surgery 1973; 73:599-606
54. Howell WH, Holt E. Two new factors in blood coagulation-heparin and proantithrombin. Am J Physiology 1918; 47:328-333
55. Jorpes JE. Heparin in the Treatment of Thrombosis. 2nd Ed. London, UK: Oxford University Press, 1946
56. Howell WH, McDonald CH. Note on the effect of repeated intravascular injections of heparin. John Hopkins Hospital 1930; 46:365-371
57. Crafoord C. Preliminary report on post-operative treatment with heparin as a preventive of thrombosis. Acta Chir Scand 1937; 79:407-426
58. Crafoord C. Heparin as a prophylactic against postoperative thrombosis. Acta Med Scand 1941; 107:116-122
59. Murray GDW. Experimental surgery: Heparin in thrombosis and embolism. Br J Surg 1940; 27:567-598
60. Crafoord C. Heparin and post-operative thrombosis. Acta Chir Scand 1939; 82:319-335
61. Brandjes DPM, Heijboer H, Buller HR, et al. Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. N Engl J Med 1992; 327:1485-1489
62. Cade JF, Buchanan MR, Boneu B, et al. A comparison of the antithrombotic and hemorrhagic effects of low-molecular-weight heparin fractions: The influence of the method of preparation. Thromb Res 1984; 35:613-625
63. Carter CJ, Kelton JG, Hirsh J, et al. The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparins and heparin. Blood 1982; 59:1239-1245
64. Handeland GF, Abidgaard GF, Holm U, et al. Dose adjusted heparin treatment of deep venous thrombosis: A comparison of unfractionated and low molecular weight heparin. Eur J Clin Pharmacol 1990; 39:107-112
65. Bratt G, Aberg W, Johansson M, et al. Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis. Thromb Haemost 1990; 64:506-510
66. Siragusa S, Cosmi B, Piovella F, et al. Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: Results of a meta-analysis. Am J Med 1996; 100:269-277
67. Carson JL, Kelley MA, Duff A, et al. The clinical course of pulmonary embolism. N Engl J Med 1992; 326:1240-1245
68. Douketis JD, Kearon C, Bates S, et al. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998; 279:458-462
69. Link KP. The discovery of dicumarol and its sequels. Circulation 1959; 19:97-107
70. Ansell JE. Oral anticoagulation therapy 50 years later. Arch Intern Med 1993; 153:586-596
71. Stahmann MA, Huebner CH, Link KP. Studies on the hemorrhagic sweet clover disease v. identification and synthesis of the hemorrhagic agent. J Biol Chem 1941; 138: 513-527
72. Allen EV, Hines EA, Kvale WF, et al. The use of dicumarol as an anticoagulant: Experience in 2,307 cases. Ann Intern Med 1947; 27:371-381
73. Pollock BE. Clinical experience with warfarin (Coumadin) sodium, a new anticoagulant. JAMA 1955; 159:1094-1097
74. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332:1661-1665
75. Schulman S, Granqvist S, Holmstrom M, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997; 336:393-398
76. Quick AJ, Stanlet-Brown M, Bancroft FW. A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 1935; 190:501-511
77. Nichol ES, Page SW. Dicumarol therapy in acute coronary thrombosis; results in fifty attacks, with review of data on embolic complications and immediate mortality in myocardial infraction. J Fla Med Assoc 1946; xxxii:365-370
78. Barker NW. The clinical use of dicumarol. Med Clin North Am 1945; July:929-935
79. Foley WT, Wright IS. Long term anticoagulant therapy for cardiovascular diseases. Am J Med Sci 1949; 217:136-142
80. Hull R, Hirsh J, Jay R, et al. Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. N Engl J Med 1982; 307:1676-1681
81. Kirkwood TBL. Calibration of reference thromboplastins and standardisation of the prothrombin time ratio. Thromb Haemost 1983; 49:238-244
82. Hirsh J, Deykin D, Poller L, et al. Therapeutic range for oral anticoagulant therapy. Chest 1986; 89:11S-15S
83. Yim JM, Albers GW, Vlasses PH. Anticoagulant therapy monitoring with international normalized ratio at us academic health centers. Ann Pharmacother 1996; 30:1390-1395
84. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy antithrombotic therapy in atrial fibrillation. Arch Intern Med. 1994; 154:1449-1457
85. Levine M, Raskob G, Hirsh J. Hemorrhagic complications of long-term anticoagulant therapy. Chest 1986; 89:16S-25S
86. Tillett WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J Exp Med 1933; 58:4850-502
87. Dalen JE. The case against fibrinolytic therapy. J Cardiovasc Med 1980; 5:799-814
88. Sasahara AA. The case for fibrinolytic therapy. J Cardiovasc Med 1980; 5:782-798
89. Goldhaber SZ. Contemporary pulmonary embolism thrombolysis. Chest 1995; 107:45S-50S
90. The TIMI Study Group. Thrombolysis in myocardial infraction (TIMI) trial: Phase I findings. N Engl J Med 1985; 312:932-936
91. Dalla-Volta S, Palla A, Santolicandro A, et al. Alteplase combined with heparin vs heparin in the treatment of acute pulmonary embolism: Plasminogen Activator Italian Multi-center Study 2. J Am Coll Cardiol 1992; 20:520-526
92. Goldhaber SZ, Haire WD, Feildstein ML, et al. Alteplase vs heparin in acute pulmonary embolism: Randomized trial assessing right-ventricular function and pulmonary perfusion. Lancet 1993; 341:507-511
93. Levine MN. Thrombolytic therapy for venous thromboembolism. Clin Chest Med 1995; 16:321-328
94. Dalen JE, Alpert JS, Hirsh J. Thrombolytic therapy for pulmonary embolism: Is it effective? Is it safe? When is it indicated? Arch Intern Med 1997; 157:2550-2556
95. Gore JM, Sloan M, Price TR, et al. Intracerebral hemorrhage, cerebral infraction and subdural hematoma after acute myocardial infraction and thrombolytic therapy in the thrombolysis in myocardial infraction study: Thrombolysis in myocardial infraction, phase II, pilot and clinical trial. Circulation 1991; 83:448-459
96. Hull RD, Raskob GE, Hirsh J. Prophylaxis of venous thromboembolism: An overview. Chest 1986; 89:374S-383S
97. Sharnoff JG, Kass HH, Mistica BA. A plan of heparinization of the surgical patient to prevent postoperative thromboembolism. Surg Gynecol Obstet 1962; 115:75-79
98. Kakkar VV, Corrigan T, Spindler J, et al. Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery: A double blind, randomized trial. Lancet 1972; 2:101-106
99. Nicolaides AN, Dupont PA, Desai S, et al. Small doses of subcutaneous sodium heparin in preventing deep venous thrombosis after major surgery. Lancet 1972; 2:890-893
100. Prevention of fatal postoperative pulmonary embolism by low doses of heparin: International Multicenter Trial. Lancet 1975; 2(pt 1):45-51
101. Claggett GP, Anderson FA, Levine MN, et al. Prevention of venous thromboembolism. Chest 1992; 102:391S-407S
102. Kakkar VV, Djazaeri B, Fok J, et al. Low-molecular-weight heparin and prevention of postoperative deep vein thrombosis. BMJ 1982; 284:375-379
103. Kakkar VV, Murray WJG. Efficacy and safety of low-molecular-weight heparin (CY216) in preventing postoperative venous thrombo-embolism: A co-operative study. Br J Surg 1985; 72:786-791
104. Turpie AGG, Levine MN, Hirsh J, et al. A randomized trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315:925-929
105. Planes A, Vochelle N, Mazas F, et al. Prevention of postoperative venous thrombosis: A randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988; 60:407-410
106. Hull RD, Raskob G, Pineo G, et al. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. N Engl J Med 1993; 329:1370-1376
107. Leclerc JR, Geerts WH, Desjardins L, et al. Prevention of venous thromboembolism after knee arthoplasty: A randomized, double-blind trial comparing enoxaparin with warfarin. Ann intern Med 1996; 124:619-626
108. O'Brien JR. Effects of salicylates on human platelets. Lancet 1968; 2:779-783
109. Medical Research Council. Effect of aspirin on postoperative venous thrombosis. Lancet 1972; 2:445-446
110. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy-III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ 1994; 308:235-246
111. Collins R, Baigent C, Sandercock P, et al. Antiplatelet therapy for thromboprophylaxis: The need for careful consideration of the evidence from randomized trials. BMJ 1994; 309:1215-1217
112. Cohen AT, Skinner JA, Kakkar VV. Antiplatelet treatment for thromboprophylaxis: A step forward or backwards? BMJ 1994; 309:1213-1215
113. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) Trial. Lancet 2000; 355:1295-1302
114. Sors H, Meyer G. Place of aspirin in prophylaxis of venous thromboembolism. Lancet 2000; 355:1288-1289
115. Geerts WH, Heit JA, Clagett GP, et al. Prevention of venous thromboembolism. Chest 2001; 119:1325-1755
116. Calnan JS, Pflug JJ, Mills CJ. Pneumatic intermittent-compression legging simulating calf-muscle pump. Lancet 1970; 2:502-503
117. Knight MTN, Dawson R. Effect of intermittent compression of the arms on deep venous thrombosis in the legs. Lancet 1976; 2:1265-1268
118. Hills NH, Pflug JJ, Jeyasingh K, et al. Prevention of deep vein thrombosis by intermittent pneumatic compression of the calf. BMJ 1972; 1:131-135
119. Caprini JA, Chucker JL, Zuckerman L, et al. Thrombosis prophylaxis using external compression. Surg Gynecol Obstet 1983; 156:599-604
120. Hull RD, Raskob GE, Gent M, et al. Effectiveness of intermittent pneumatic leg compression for preventing deep vein thrombosis after total hip replacement. JAMA 1990; 263:2313-2317
121. Francis CW, Pellegrini VD, Marder VJ, et al. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement. JAMA 1992; 267:2911-2915
122. Wilkins RW, Mixter G, Stanton JR, et al. Elastic stockings in the prevention of pulmonary embolism: A preliminary report. N Engl J Med 1952; 246:360-364
123. Browse NL, Jackson BT, Mayo ME, et al. The value of mechanical methods of preventing postoperative calf vein thrombosis. Br J Surg 1974; 61:219-223
124. Rosengarten DS, Laird J, Jeyasingh K, et al. The failure of compression stocking (Tubigrip) to prevent deep venous thrombosis after operation. Br J Surg 1970; 57:296-299
125. Scurr JH, Ibrahim SZ, Faber RG, et al. The efficacy of graduated compression stockings in the prevention of deep vein thrombosis. Br J Surg 1977; 64:371-373
126. Allan A, Williams JT, Bolton JP, et al. The use of graduated compression stockings in the prevention of postoperative deep vein thrombosis. Br J Surg 1983; 70:1722-1724
127. Wells PS, Lensing AWA, Hirsh J. Graduated compression stockings in the prevention of postoperative venous thromboembolism. Arch Intern Med 1994; 154:67-72
128. Anderson FA, Wheeler HB, Goldberg RJ, et al. Physician practices in the prevention of venous thromboembolism. Ann Intern Med 1991; 115:591-595
129. Stratton MA, Anderson FA, Bussey HI, et al. Prevention of venous thromboembolism: Adherence to the 1995 American College of Chest Physicians consensus guidelines for surgical patients. Arch Intern Med 2000; 160: 334-340
130. Dalen JE, Banas JS, Brooks HL, et al. Resolution rate of acute pulmonary embolism in man. N Engl J Med 1969; 280:1194-1199
131. Paraskos JA, Adelstein SJ, Smith RE, et al. Late prognosis of acute pulmonary embolism. N Engl J Med 1973; 289:55-58
132. Benotti JR, Ockene IS, Alpert JS, et al. The clinical profile of unresolved pulmonary embolism. Chest 1983; 84: 669-678
133. Moser KM, Houk VN, Jones RC, et al. Chronic, massive thrombotic obstruction of the pulmonary arteries. Circulation 1965; 32:377-385